Excellent and important question!
I'm not familiar with LBT Innovations so I can't compare Resapp's business model or product directly. But our Resapp team have been very proactive in forging strong relationships with key potential clients and influencers in our target markets:
- The research partners in the US who have been working with us on the FDA trials.
- A German hospital chain who have commenced a pilot project for deploying ResappDx across their sites.
- Regulatory authorities around the world.
- Medecins sans frontieres intend to trial the product once it's field-ready for their operating context.
And because the product is software, free of any custom-built hardware, it can be rapidly deployed anywhere in the world without the need for physical supply logistics.
rap chart, page-616
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #